Related Experiment Video
Updated: Jun 15, 2026
06:49
Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine (PEI)
Published on: May 24, 2022
Lentiviral vector-mediated transgenesis in human embryonic stem cells
1Departments of Anatomy and Neurology, School of Medicine and Public Health, WiCell Institute, University of Wisconsin, Madison, WI, USA.
Methods in Molecular Biology (Clifton, N.J.)
|March 13, 2010
Summary
We developed an efficient lentiviral vector method to create genetically modified human embryonic stem cells (hESCs). This technique enhances the utility of hESCs for biological research and regenerative medicine applications.
Area of Science:
- Stem Cell Biology
- Genetics
- Regenerative Medicine
Background:
- Human embryonic stem cells (hESCs) are crucial for understanding human development and disease.
- Current limitations exist in modifying hESCs for advanced research and therapeutic applications.
Purpose of the Study:
- To establish a versatile and efficient method for creating genetically modified human embryonic stem cell lines.
- To broaden the utility of hESCs through genetic engineering.
Main Methods:
- Utilized a lentiviral vector-mediated gene delivery system.
- Established stable, transgenic human embryonic stem cell lines.
Main Results:
- Demonstrated an efficient method for generating transgenic hESCs.
- Successfully created stable genetically modified hESC lines.
Conclusions:
- Lentiviral vector technology provides an effective means to genetically modify hESCs.
- This advancement facilitates the use of hESCs in regenerative medicine and biological studies.
